Immunohistochemical profile for unknown primary adenocarcinoma

Area of Science:

• Oncology
• Molecular Pathology
• Cancer Research

Background:

• Cancers of unknown primary (CUP) present a significant clinical challenge.
• There is a critical need for tailored treatment strategies based on tumor characteristics.
• Immunohistochemical profiles (IPs) offer a promising avenue for classifying CUP.

Purpose of the Study:

• To develop and validate an algorithm for classifying unknown primary adenocarcinoma using immunohistochemical profiles (IPs).
• To assess the diagnostic accuracy (sensitivity and specificity) of the developed algorithm.
• To investigate the prognostic value of identified IPs in unfavorable CUP subsets.

Main Methods:

• An algorithm was developed using 15 molecular markers on formalin-fixed paraffin-embedded tissue samples from 71 CUP patients.
• Tumors were classified into 9 subsets based on primary tumor site using the algorithm and IPs.
• Sensitivity and specificity of the algorithm were evaluated against known adenocarcinoma profiles.

Main Results:

• The algorithm achieved 80.3% sensitivity and 97.6% specificity in classifying CUP.
• Identified IPs included lung (17), digestive (13), gynecological (9), prostate (7), liver/kidney (6), and breast (4) origins.
• Gynecological IPs showed the highest chemotherapy response rate, and gynecological/lung IPs correlated with longer progression-free survival.

Conclusions:

• Immunohistochemical profiles identified in this study can effectively stratify prognosis for unfavorable subsets of unknown primary adenocarcinoma.
• IPs serve as independent prognostic factors, guiding personalized treatment approaches.
• This algorithm aids in determining potential primary sites and predicting patient outcomes for CUP.